We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

128 hedge funds and large institutions have $447M invested in Array Biopharma Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51% less call options, than puts

Call options by funds: $396K | Put options by funds: $809K

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$396K
Puts
$809K
Net Calls
-$413K
Net Calls Change
-$413K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$942K +$1.12M +207,419 New
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$924K +$1.09M +203,491 New
UOC
53
UBS O'Connor
Illinois
$908K +$1.08M +200,000 New
Morgan Stanley
54
Morgan Stanley
New York
$725K +$859K +159,727 New
CCMH
55
Cornerstone Capital Management Holdings
New York
$709K +$839K +155,948 New
Wells Fargo
56
Wells Fargo
California
$692K +$820K +152,489 New
Jacobs Levy Equity Management
57
Jacobs Levy Equity Management
New Jersey
$664K +$786K +146,199 New
Bank of America
58
Bank of America
North Carolina
$632K +$749K +139,234 New
JP Morgan Chase
59
JP Morgan Chase
New York
$576K +$682K +126,827 New
CNB
60
City National Bank
California
$551K +$653K +121,470 New
Swiss National Bank
61
Swiss National Bank
Switzerland
$517K +$612K +113,800 New
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$502K +$594K +110,495 New
CS
63
Credit Suisse
Switzerland
$470K +$557K +103,540 New
JG
64
Jefferies Group
New York
$456K +$540K +100,387 New
MLICM
65
Metropolitan Life Insurance Company (MetLife)
New York
$444K +$526K +97,731 New
ProShare Advisors
66
ProShare Advisors
Maryland
$444K +$526K +97,856 New
First Manhattan
67
First Manhattan
New York
$406K +$350K +65,000 New
NFA
68
Nationwide Fund Advisors
Ohio
$403K +$477K +88,730 New
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$392K +$464K +86,296 New
State Board of Administration of Florida Retirement System
70
State Board of Administration of Florida Retirement System
Florida
$386K +$457K +84,962 New
ARTA
71
A.R.T. Advisors
New York
$377K +$447K +83,074 New
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
$365K +$432K +80,357 New
AIG
73
American International Group
New York
$364K +$431K +80,162 New
HCM
74
Highbridge Capital Management
New York
$354K +$419K +77,864 New
VOYA Investment Management
75
VOYA Investment Management
Georgia
$351K +$416K +77,330 New
1 2
3
4 5

ARRY Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q2 2013, worth a combined $447M.

Buyers outnumbered sellers: 128 funds opened new ARRY positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Array Biopharma Inc (ARRY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $447M of Array Biopharma Inc stock for Q2 2013.
  • 128 funds opened new Array Biopharma Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.